[go: up one dir, main page]

HK1062895B - 含有n-{5-[4-(4-甲基-piperazino-甲基)-苯氨基]-2-甲基苯基}-4-(3-吡啶)-2嘧啶-胺和二膦酸盐的联合药物 - Google Patents

含有n-{5-[4-(4-甲基-piperazino-甲基)-苯氨基]-2-甲基苯基}-4-(3-吡啶)-2嘧啶-胺和二膦酸盐的联合药物 Download PDF

Info

Publication number
HK1062895B
HK1062895B HK04105830.9A HK04105830A HK1062895B HK 1062895 B HK1062895 B HK 1062895B HK 04105830 A HK04105830 A HK 04105830A HK 1062895 B HK1062895 B HK 1062895B
Authority
HK
Hong Kong
Prior art keywords
combination
combination according
treatment
methyl
study
Prior art date
Application number
HK04105830.9A
Other languages
German (de)
English (en)
French (fr)
Other versions
HK1062895A1 (zh
Inventor
Christian Bruns
Elisabeth Buchdunger
Terence O'reilly
Sandra Leta Silberman
Markus Wartmann
Gisbert Weckbecker
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Priority claimed from PCT/EP2002/005362 external-priority patent/WO2002092091A1/en
Publication of HK1062895A1 publication Critical patent/HK1062895A1/zh
Publication of HK1062895B publication Critical patent/HK1062895B/zh

Links

HK04105830.9A 2001-05-16 2002-05-15 含有n-{5-[4-(4-甲基-piperazino-甲基)-苯氨基]-2-甲基苯基}-4-(3-吡啶)-2嘧啶-胺和二膦酸盐的联合药物 HK1062895B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29142701P 2001-05-16 2001-05-16
US60/291,427 2001-05-16
PCT/EP2002/005362 WO2002092091A1 (en) 2001-05-16 2002-05-15 Combination comprising n-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2pyrimidine-amine and a chemotherapeutic agent

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
HK07102879.5A Division HK1098343A (zh) 2001-05-16 2004-08-05 含有n-{5-[4-(4-甲基-呱嗪并-甲基-)苯甲醯基醯胺基]-2-甲基苯基}-4-(3-吡啶基)-2-嘧啶-胺和化学治疗剂的组合物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
HK07102879.5A Addition HK1098343A (zh) 2001-05-16 2004-08-05 含有n-{5-[4-(4-甲基-呱嗪并-甲基-)苯甲醯基醯胺基]-2-甲基苯基}-4-(3-吡啶基)-2-嘧啶-胺和化学治疗剂的组合物

Publications (2)

Publication Number Publication Date
HK1062895A1 HK1062895A1 (zh) 2004-12-03
HK1062895B true HK1062895B (zh) 2007-12-14

Family

ID=

Similar Documents

Publication Publication Date Title
EP1392313B1 (en) Combination comprising n- 5- 4-(4-methyl-piperazino-methyl)-benzoylamido|-2-methylphenyl -4-(3-pyridyl)-2pyrimidine-amine and a biphosphonate
AU2002342335A1 (en) Combination comprising N-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2pyrimidine-amine and a chemotherapeutic agent
KR101712231B1 (ko) 카바지탁셀의 신규한 항종양 용도
KR20160078987A (ko) 플리나불린 및 탁산의 조합에 의한 암 치료
JP2010159271A (ja) エポシロンを含有する組合せ剤およびその医薬上の使用
KR20240104138A (ko) 니로가세스타트를 사용한 조성물 및 치료
WO2022090443A1 (en) Administration and dose regimen for a combination of a bcl-2 inhibitor and a mcl1 inhibitor
EP1251850B1 (en) Use of a combination preparation in cancer therapy
Lana et al. Principles of chemotherapy
HK1062895B (zh) 含有n-{5-[4-(4-甲基-piperazino-甲基)-苯氨基]-2-甲基苯基}-4-(3-吡啶)-2嘧啶-胺和二膦酸盐的联合药物
AU2005246965B2 (en) Combination comprising N-{5-[4(4-methyl-piperazino-methyl)-bezoylamido]-2-methylphenyl}-4-(3-pyridyl)-2pyrimidine-amine and a chemotherapeutic agent
AU2008203201A1 (en) Combination comprising N-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2pyrimidine-amine and a chemotherapeutic agent
EP1704863A2 (en) Combination comprising N-5-4-(4-Methyl-Piperazino-Methyl-)Benzoyla Mido]-2-Methylphenyl -4-(3-Pyridyl)-2Phyrimidine-amine and a chemotherapeutic agent
HK1098343A (zh) 含有n-{5-[4-(4-甲基-呱嗪并-甲基-)苯甲醯基醯胺基]-2-甲基苯基}-4-(3-吡啶基)-2-嘧啶-胺和化学治疗剂的组合物
KR20070037498A (ko) 에포틸론 조합물
CN100355423C (zh) 用于治疗肿瘤的包含血管抑制化合物和烷化剂的组合
WO2022216930A1 (en) Novel mda-9 antagonist with anti-metastatic potential
JP2005531622A5 (zh)